AMRN.US Amarin Corporation PLC

Healthcare Biotechnology USA Stocks
11.38 USD
Close of Nov 14, 2026
11.25 17.31
Market cap
USD 478M
P/E
-
P/B
1.10x
ROE
-5.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is AMRN.US undervalued?

Graham number

The Graham number of Amarin Corporation PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amarin Corporation PLC fundamental analysis

No fundamental analysis for Amarin Corporation PLC yet.

Amarin Corporation PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amarin Corporation PLC

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesa…

Full company profile